UNSPSC 51203601: Bucillamine

This classification denotes an antioxidant with the molecular formula C7H13NO3S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) R80LRA5WTF, chemically known as l-cysteine, n-(2-mercapto-2-methyl-1-oxopropyl)- but more generally known as bucillamine, which bears US NIH Compound Identifier 2459. European Medicines Agency schedules Bucillamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05944MIG.

UNSPSC 51203601 Bucillamine, a Commodity code, does not align with recent state and local procurement activity. The four most-recent opportunities posted under this code involve naloxone and drug deactivation systems, prescription pharmacy benefit programs, general medical and first aid supplies for emergency response, and generic pharmaceuticals and over-the-counter products through cooperative purchasing — none of which relate to bucillamine, a disease-modifying antirheumatic drug used in rheumatoid arthritis treatment. The mismatch suggests either a coding error in how opportunities were tagged at the source or that bucillamine procurement is not presently a focus of state and local health systems in the tracked opportunity window.

The geographic spread of the tagged opportunities spans Florida (Seminole County), Texas (Health and Human Services Commission), and multi-state cooperative arrangements (Minnesota Multistate Cooperative Purchasing Alliance serving Minnesota and Oregon), but these issuers and their procurement focus bear no practical relevance to bucillamine supply. No meaningful activity or demand signal emerges for bucillamine as a standalone commodity under this code in the current state and local procurement landscape.